News

As Josh Johnson slides into the host chair at "The Daily Show" this week, he's riding a viral wave for his stand-up set ...
Johnson & Johnson's stock offers value with promising MedTech growth, raised guidance, strong dividends, and bullish ...
We recently published 10 Most Undervalued Pharma Stocks To Buy Now. Johnson & Johnson stands second among the most ...
Johnson & Johnson halved its expectations for costs this year related to new tariffs and raised its full-year sales and ...
The healthcare company's payout currently yields 3.3%, more than double the S&P 500 's ( ^GSPC 0.32%) dividend yield (near a ...
We recently published 10 Stocks Jim Cramer Discussed As He Shared Key Insights From Morgan Stanley’s CEO. Johnson & Johnson ...
Johnson & Johnson ( ($JNJ) ) has released its Q2 earnings. Here is a breakdown of the information Johnson & Johnson presented to its investors.
Johnson & Johnson is partnering with Pacira BioSciences for osteoarthritis of the knee, according to a July 22 news release. The agreement adds Zilretta, an injectable osteoarthritis treatment, to ...